Your browser doesn't support javascript.
loading
MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors.
Knorr, K L B; Schneider, P A; Meng, X W; Dai, H; Smith, B D; Hess, A D; Karp, J E; Kaufmann, S H.
Afiliação
  • Knorr KL; Department of Molecular Pharmacology and Experimental Therapeutics, Rochester, MN, USA.
  • Schneider PA; Division of Oncology Research, Mayo Clinic, Rochester, MN, USA.
  • Meng XW; Department of Molecular Pharmacology and Experimental Therapeutics, Rochester, MN, USA.
  • Dai H; Division of Oncology Research, Mayo Clinic, Rochester, MN, USA.
  • Smith BD; Department of Molecular Pharmacology and Experimental Therapeutics, Rochester, MN, USA.
  • Hess AD; Division of Oncology Research, Mayo Clinic, Rochester, MN, USA.
  • Karp JE; Division of Hematological Malignancies, Sidney Kimmel Cancer Center, Johns Hopkins, Baltimore, MD, USA.
  • Kaufmann SH; Division of Hematological Malignancies, Sidney Kimmel Cancer Center, Johns Hopkins, Baltimore, MD, USA.
Cell Death Differ ; 22(12): 2133-42, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26045051
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Regulação para Cima / Apoptose / Proteínas Proto-Oncogênicas c-bcl-2 / Ciclopentanos Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Regulação para Cima / Apoptose / Proteínas Proto-Oncogênicas c-bcl-2 / Ciclopentanos Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article